Wall Street Zen downgraded shares of Gyre Therapeutics (NASDAQ:GYRE – Free Report) from a buy rating to a hold rating in a research note published on Saturday morning. Several other analysts also recently issued reports on GYRE. Zacks Research upgraded Gyre Therapeutics from a “strong sell” rating to a “hold” rating in a research report […]

Wall Street Zen downgraded shares of MidCap Financial Investment (NASDAQ:MFIC – Free Report) from a hold rating to a sell rating in a research report report published on Saturday morning. A number of other research analysts have also commented on the company. Wells Fargo & Company cut their price target on MidCap Financial Investment from […]

Wall Street Zen cut shares of Exagen (NASDAQ:XGN – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday. A number of other equities research analysts have also recently issued reports on the company. William Blair reiterated an “outperform” rating on shares of Exagen in a […]

Wall Street Zen cut shares of Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday morning. CRVS has been the topic of a number of other research reports. HC Wainwright raised their target price on shares of Corvus Pharmaceuticals from $11.00 […]

Wall Street Zen cut shares of Oruka Therapeutics (NASDAQ:ORKA – Free Report) from a hold rating to a sell rating in a research note published on Sunday morning. Several other research analysts also recently commented on the company. Jefferies Financial Group assumed coverage on Oruka Therapeutics in a research report on Thursday, November 13th. They […]

Wall Street Zen lowered shares of Pool (NASDAQ:POOL – Free Report) from a hold rating to a sell rating in a research note released on Saturday. Other analysts also recently issued reports about the company. Stifel Nicolaus dropped their price objective on Pool from $240.00 to $232.00 and set a “hold” rating for the company […]

Wall Street Zen downgraded shares of Steel Dynamics (NASDAQ:STLD – Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Saturday. Other equities research analysts have also recently issued research reports about the company. Morgan Stanley restated an “equal weight” rating and issued a $194.00 price target […]

Wall Street Zen lowered shares of Arrive AI (NASDAQ:ARAI – Free Report) from a hold rating to a sell rating in a report published on Saturday. Separately, Weiss Ratings restated a “sell (e)” rating on shares of Arrive AI in a research note on Monday, December 29th. One investment analyst has rated the stock with […]

Hoth Therapeutics (NASDAQ:HOTH – Get Free Report) was upgraded by Wall Street Zen to a “sell” rating in a note issued to investors on Saturday. A number of other brokerages also recently weighed in on HOTH. D. Boral Capital reaffirmed a “buy” rating and set a $5.00 target price on shares of Hoth Therapeutics in […]

Wall Street Zen downgraded shares of Acrivon Therapeutics (NASDAQ:ACRV – Free Report) from a hold rating to a sell rating in a research report released on Sunday morning. ACRV has been the topic of a number of other reports. HC Wainwright reiterated a “buy” rating and issued a $19.00 target price on shares of Acrivon […]

Wall Street Zen downgraded shares of Edgewise Therapeutics (NASDAQ:EWTX – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. EWTX has been the topic of several other reports. Piper Sandler reissued an “overweight” rating on shares of Edgewise Therapeutics in a research note on Monday, February […]

Wall Street Zen downgraded shares of Realloys (NASDAQ:ALOY – Free Report) from a hold rating to a sell rating in a research report released on Saturday morning. Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Realloys in a report on Wednesday, January 21st. One investment analyst has rated the stock with a […]

Wall Street Zen cut shares of Cassava Sciences (NASDAQ:SAVA – Free Report) from a hold rating to a sell rating in a research note released on Saturday morning. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Cassava Sciences in a research note on Friday, December 26th. One analyst has rated the stock […]

Wall Street Zen cut shares of Sharplink Gaming (NASDAQ:SBET – Free Report) from a hold rating to a sell rating in a research report released on Saturday. Several other brokerages have also weighed in on SBET. Weiss Ratings reissued a “sell (d)” rating on shares of Sharplink Gaming in a report on Thursday, January 22nd. […]